Spasticity: Essentials of Assessment
December 13, 2022
December 13, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Catalyst Medical Education, LLC and AKH Inc., Advancing Knowledge in Healthcare .
This activity is supported by an educational grant from AbbVie Inc. and Ipsen Biopharmaceuticals, Inc.
- Physicians — maximum of 0.5 AMA PRA Category 1 Credit(s)™
- Nurses — 0.5 Contact Hours
- Nurse Practitioners — 0.5 Contact Hours (0.5 hour(s) of pharmacology)
All other healthcare professionals completing this course will be issued a statement of participation.
This initiative is intended for US neurologists, physiatrists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, physical therapists, and occupational therapists.
In this activity, Dr. Heakyung Kim will review the clinical presentation of spasticity and cover assessment strategies, including clinical scales, used to evaluate patients and inform treatment decision-making. For additional activities and other information, please visit www.impact-smd.com/.
Upon completion of this activity, participants should be better able to:
- Describe the clinical presentation, diagnosis, and treatment of patients with spasticity
Heakyung Kim, MD
Professor & Chair
Kimberly-Clark Distinguished Chair in Mobility Research
Physical Medicine & Rehabilitation
UT Southwestern Medical Center
Heakyung Kim, MD serves as Professor and Chair of Physical Medicine & Rehabilitation (PM&R) and Kimberly-Clark Distinguished Chair in Mobility Research at the University of Texas Southwestern (UTSW) Medical Center in Dallas, Texas. Dr. Kim joined UTSW on May 1, 2022.
She received her medical degree from the Ewha Womans University College of Medicine in Seoul, South Korea, and was trained at the Department of Rehabilitation Medicine of Yonsei University College of Medicine in Seoul, South Korea, and at the Department of Rehabilitation of the University of Medicine and Dentistry of New Jersey-New Jersey Medical School/Kessler Institute for Rehabilitation. She is a board-certified physiatrist in the United States and South Korea and holds subspecialty boards in pediatric rehabilitation medicine and brain injury medicine.
Prior to UTSW, Dr. Kim served as Vice Chair and A. David Gurewitsch Professor of Rehabilitation Medicine and as Professor of Pediatrics and Orthopedic Surgery at Columbia University Irving Medical Center (CUIMC); Director of Pediatric PM&R at Morgan Stanley Children’s Hospital, Weill Cornell Medicine; and Chief of Physiatry Department at Blythedale Children’s Hospital. She was the founding director of the Pediatric Rehabilitation Medicine Fellowship Program at CUIMC-New York Presbyterian Hospital. Dr. Kim also served as Associate Director of Pediatric Rehabilitation Medicine in the Weinberg Family Cerebral Palsy Center at Columbia University. Dr. Kim joined New York Presbyterian in 2011, prior to which she served as an assistant chief for the Division of Child Development, Rehabilitation and Metabolic Disease; a Medical Director of Pediatric Rehabilitation Medicine; and a Medical Director of the Cerebral Palsy Program at the Children’s Hospital of Philadelphia between 1998 and 2010.
Dr. Kim has been recognized as one of “America’s Top Doctors” since 2003 consecutively as well as a “Super Doctor” by the New York Times and selected as one of the Exceptional Women in Medicine and Best of the Best (Top 1% of America’s Most Honored Doctors) by American Registry. She has been an outstanding teacher and mentor and received “Teacher of the Year” awards 4 times.
She specializes in single-event multilevel chemoneurolysis with botulinum neurotoxin and phenol/alcohol injections, botulinum neurotoxin injections to salivary glands, and sexuality and pain management in children and adults with cerebral palsy. Her research interests focus on people with cerebral palsy, especially spasticity and drooling management with botulinum neurotoxin, robotic therapy and exercise for spastic muscles in children with cerebral palsy, and lifespan care for people with cerebral palsy including sexuality. She is nationally and internationally regarded as an expert in pediatric rehabilitation medicine, especially care for people with cerebral palsy, including pain and spasticity management and botulinum neurotoxin injections to salivary glands. She is also a renowned sonographer for muscles and nerves. She is a World Health Organization member of a development group to prepare a Package of Rehabilitation Intervention for people with cerebral palsy. She has been actively providing remote teaching on musculoskeletal ultrasound via YouTube during the COVID pandemic.
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit provided by AKH Inc., Advancing Knowledge in Healthcare
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
0.5 ANCC contact hours.
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803.
This activity is approved for 0.5 contact hour(s) (which includes 0.5 hour(s) of pharmacology).
Disclosures of Conflicts of Interest
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Heakyung Kim, MD, has disclosed no financial relationships.
Jessica F Marshall, PhD, Medical Writer, has no financial relationships to disclose.
Trish Brignoni, AKH Director of Operations, has disclosed no financial relationships.
Wendi Martin, AKH Continuing Education Coordinator, has disclosed no financial relationships.
AKH and Catalyst Medical Education, LLC Planners and Reviewers, have disclosed no financial relationships.
All of the relevant financial relationships listed for these individuals have been mitigated.
Instructions for Participation and Credit
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
If you have questions about this activity, please contact AKH Inc. at [email protected].